lobbying_activities: 2341049

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2341049	f50ea529-d2a0-4527-8379-e979365e1e95	Q3	INDEPENDENT PHARMACY COOPERATIVE	313098	INDEPENDENT PHARMACY COOPERATIVE	2019	third_quarter	PHA	Improving Transparency and Accuracy in Medicare Part D Spending Act S.988/ HR 803-IPC supports all pharmacy price concessions be reflected at the point-of-sale. Proposed Regulation CMS-4180-P Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses. IPC supports. Proposed Regulation - OIG-0936-P Fraud and Abuse Removal of Federal Social Security Act Safe Harbor Protections for Prescription Drug Manufacturer Rebates and Safe Harbor Protections for Prescription Drug Point-of-Sale Price Reductions-IPC supports if a reasonable timeline is given to implement.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		30000	0	0	2019-10-14T09:45:31.787000-04:00